ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Wednesday, 18 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual General Meeting

AstraZeneca Pharma India Annual General Meeting

AstraZeneca Pharma India seeks shareholder approval by postal ballot to appoint Krishnamurthy Narayanan Iyer as Independent Director for five years. E-voting closes December 17, 2026.

Source

BSE filing, NSE: ASTRAZEN. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

AstraZeneca Pharma India Ltd: key numbers

Share price
₹6,168.00
Market cap
₹15,420 Cr
Revenue (annual)
₹2,276 Cr
Net profit (annual)
₹187.5 Cr
P/E (TTM)
86.8×Sector 48.6×
Promoter holding
75.00%+0.00% QoQ
FII holding
2.64%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from AstraZeneca Pharma India Ltd

All →
14:00 IST BSE
Partnership

AstraZeneca Pharma India Partnership

AstraZeneca Pharma India signed a Letter of Intent with Strand Life Sciences to explore healthcare collaboration in India. No specific project value or new entity is involved.

Other annual general meeting announcements

All →